Retail cut yields of Rambouillet wether lambs fed the beta-adrenergic agonist L644,969.
Twenty Rambouillet wether lambs were given ad libitum access to a diet with (BAA, n = 10) or without (control, n = 10) 1 ppm of the beta-adrenergic agonist L644,969. Lambs were fed to a constant slaughter weight end point of 54.5 kg. Carcasses were fabricated to yield bone-in and boneless cuts that were trimmed progressively to 1.27, .64, .32, and .00 cm of s.c. fat remaining. Addition of BAA did not affect growth traits. Actual and adjusted fat thickness, body wall thickness, and percentage of kidney-pelvic fat did not differ between control and BAA lambs. However, BAA increased longissimus muscle area, longissimus muscle depth, and leg score while decreasing USDA yield grade. The BAA increased carcass conformation scores and decreased flank lean color scores. No other carcass quality measurements were affected by BAA. Addition of BAA did not affect overall carcass yields of bone-in retail cuts. However, BAA increased overall carcass yields of boneless retail cuts regardless of fat trim level. The BAA increased bone-in leg yield. Yield of boneless sirloin, bone-in loin and boneless loin were not affected by BAA. For these cuts, the percentage change from the control was highly dependent on fat trim level. There was no difference in short-cut, shank-off, semiboneless leg yield between control and BAA. Addition of BAA did not affect yield of bone-in rack regardless of fat trim level. However, BAA greatly increased yield of boneless ribeye. The BAA did not affect yield of bone-in or boneless shoulder.(ABSTRACT TRUNCATED AT 250 WORDS)
Shackelford
S D
SD
Department of Animal Science, Texas A&M University, College Station 77843-2471.
Edwards
J W
JW
Smarr
E K
EK
Savell
J W
JW
D000273:Adipose Tissue / Q000187:drug effects / Q000254:growth & development; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D001947:Breeding; D008297:Male; D008460:Meat / Q000592:standards*; D024510:Muscle Development; D009132:Muscles / Q000187:drug effects*; D011725:Pyridines / Q000494:pharmacology*; D012756:Sheep / Q000254:growth & development*; D015430:Weight Gain / Q000187:drug effects; D014935:Wool / Q000187:drug effects / Q000254:growth & development
D000318:Adrenergic beta-Agonists; D011725:Pyridines; C061557:6-amino-alpha-(((1-methyl-3-phenylpropyl)amino)methyl)-3-pyridine methanol